BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7688865)

  • 41. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.
    Kwekkeboom J; De Boer M; Tager JM; De Groot C
    Immunology; 1993 Jul; 79(3):439-44. PubMed ID: 7691726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels.
    Santos-Argumedo L; Teixeira C; Preece G; Kirkham PA; Parkhouse RM
    J Immunol; 1993 Sep; 151(6):3119-30. PubMed ID: 8397252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.
    Brines RD; Klaus GG
    Int Immunol; 1993 Nov; 5(11):1445-50. PubMed ID: 7505108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of surface immunoglobulin in B lymphocyte activation.
    Finkelman FD; Vitetta ES
    Fed Proc; 1984 Aug; 43(11):2624-32. PubMed ID: 6611276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A role for immunoglobulin D: interference with tolerance induction.
    Carsetti R; Köhler G; Lamers MC
    Eur J Immunol; 1993 Jan; 23(1):168-78. PubMed ID: 8419167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-beta, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis.
    Holder MJ; Knox K; Gordon J
    Eur J Immunol; 1992 Oct; 22(10):2725-8. PubMed ID: 1382997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.
    Kozono Y; Duke RC; Schleicher MS; Holers VM
    Eur J Immunol; 1995 Apr; 25(4):1013-7. PubMed ID: 7737272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes.
    Parry SL; Holman MJ; Hasbold J; Klaus GG
    Eur J Immunol; 1994 Apr; 24(4):974-9. PubMed ID: 7512037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice.
    Nomura T; Han H; Howard MC; Yagita H; Yakura H; Honjo T; Tsubata T
    Int Immunol; 1996 Jun; 8(6):867-75. PubMed ID: 8671676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40.
    Inui S; Kaisho T; Kikutani H; Stamenkovic I; Seed B; Clark EA; Kishimoto T
    Eur J Immunol; 1990 Aug; 20(8):1747-53. PubMed ID: 1698631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporin A blocks surface IgM-mediated growth inhibition in an immature B lymphoma, BKS-2.
    Udhayakumar V; Muthukkumar S; Subbarao B
    Eur J Immunol; 1991 Oct; 21(10):2605-8. PubMed ID: 1915562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD40 ligand-transduced co-stimulation of T cells in the development of helper function.
    van Essen D; Kikutani H; Gray D
    Nature; 1995 Dec; 378(6557):620-3. PubMed ID: 8524396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD40L: a multi-functional ligand.
    Armitage RJ; Maliszewski CR; Alderson MR; Grabstein KH; Spriggs MK; Fanslow WC
    Semin Immunol; 1993 Dec; 5(6):401-12. PubMed ID: 7510138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD40 ligand/CD40 deficiency.
    Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
    Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome.
    Henriquez NV; Rijkers GT; Zegers BJ
    J Immunol; 1994 Jul; 153(1):395-9. PubMed ID: 7515927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [B lymphocyte antigen CD40 and its ligand, CD40L].
    Tsubata T; Nomura T; Nishitani S
    Seikagaku; 1995 Jan; 67(1):51-5. PubMed ID: 7535832
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells.
    Benhamou LE; Cazenave PA; Sarthou P
    Eur J Immunol; 1990 Jun; 20(6):1405-7. PubMed ID: 2369921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.